Heart Disease Trial, Recruiting (NCT05250557)

Heart Disease Trial, Recruiting NCT05250557 Sponsor: Seoul National University Hospital Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05250557 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 20 years or older
People who have already had a successful FFR measurement and pullback tracing performed (this is a heart artery pressure test used to check for blockages)

Who may not be able to join:

People with severe chronic kidney disease (where kidney filtering function is measured below a certain level)
People who have had a certain type of serious heart attack (ST-elevation myocardial infarction) within the last 72 hours, or who have previously had coronary artery bypass graft (open-heart bypass) surgery
People with a primary disease of the heart muscle itself or the heart valves
People whose heart pumping function is significantly reduced (the heart is pumping less than 30% of its normal capacity)
People whose condition is medically unstable at the time of the trial (confirm with trial site)
People with a life expectancy of less than 2 years

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bon-Kwon Koo, MD, PhD, Seoul National University Hospital

Phone: +82-2-2072-2062

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05250557

Sponsor: Seoul National University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: +82-2-2072-2062

More information: https://clinicaltrials.gov/study/NCT05250557

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 20 years or older
People who have already had a successful FFR measurement and pullback tracing performed (this is a heart artery pressure test used to check for blockages)

Who may not be able to join:

People with severe chronic kidney disease (where kidney filtering function is measured below a certain level)
People who have had a certain type of serious heart attack (ST-elevation myocardial infarction) within the last 72 hours, or who have previously had coronary artery bypass graft (open-heart bypass) surgery
People with a primary disease of the heart muscle itself or the heart valves
People whose heart pumping function is significantly reduced (the heart is pumping less than 30% of its normal capacity)
People whose condition is medically unstable at the time of the trial (confirm with trial site)
People with a life expectancy of less than 2 years

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Seoul National University Hospital

Registry

ClinicalTrials.gov

Start date

1 August 2021

Est. completion

31 December 2025

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Adverse cardiovascular event according to ΔFFR (Deferral of PCI group); Adverse cardiovascular event according to post-PCI FFR (PCI group)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov